Connecting the R&D of auto-immune disease therapies – starting from the type 1 diabetes perspective
Over a long period of time, the Øresund region has built up strong and internationally recognised competencies within the fields of screening, genetics and immunology in type 1 diabetes and other autoimmune diseases. The coupling between type 1 diabetes and other autoimmune diseases contains an immense potential for the development of new drugs and therapies. This meeting will give an insight in some of the coordinating and individual R&D efforts that are existing in Medicon Valley today in the field of type 1 diabetes and the bridges to other auto-immune diseases.
Until we can meet in large groups, we have decided to bring the possibility to share experiences in a shorter webinar format in stead of our regular networking meetings.
More information and updated programme: